Clinical Trials Directory

Trials / Conditions / Recurrent Mucoepidermoid Carcinoma of the Oral Cavity

Recurrent Mucoepidermoid Carcinoma of the Oral Cavity

16 registered clinical trials studyying Recurrent Mucoepidermoid Carcinoma of the Oral Cavity — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedAcetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoi
NCT02123511
Mayo ClinicPhase 2
Completed18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis
NCT01806675
Sanjiv Sam GambhirPhase 1 / Phase 2
TerminatedTransoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
NCT01254734
City of Hope Medical CenterN/A
CompletedL-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For
NCT01155609
University of WashingtonN/A
CompletedCetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cance
NCT01637194
Fox Chase Cancer CenterPhase 1
RecruitingTransoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NCT01473784
Ohio State University Comprehensive Cancer CenterN/A
CompletedBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Pri
NCT00492089
National Cancer Institute (NCI)Phase 2
CompletedErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Nec
NCT00397384
National Cancer Institute (NCI)Phase 1
CompletedPhotodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck
NCT00470496
Roswell Park Cancer InstitutePhase 1
CompletedErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidne
NCT00101348
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00089362
National Cancer Institute (NCI)Phase 1
CompletedGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Can
NCT00068497
National Cancer Institute (NCI)N/A
CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
NCT00030498
National Cancer Institute (NCI)Phase 1
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedBevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and
NCT00023959
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1